Should someone with drug-resistant epilepsy travel to China for care?

Deciding whether to seek care in China involves two linked questions: what additional medical value the referral may offer, and whether the person can complete the journey and continuing care safely. Drug resistance does not automatically require international travel. Someone with suitable local services may benefit from an additional opinion without relocating, while a person who has never had a comprehensive assessment should not assume that years of seizures mean there are no further options. The following discussion uses information checked through September 9, 2026 to support planning with the existing clinician and the receiving team in China. Jehi et al.: Timing of referral for epilepsy surgery evaluation, ILAE consensus, 2022CDC Yellow Book 2026: Travelers with Chronic Illnesses

Key takeaways

These excerpts come from the original article. Read the full sections below for context.

Some patients continue to have seizures despite several medications but have never been assessed systematically for surgical options. Others have conflicting descriptions of their events, making the treatment rationale uncertain. A person with recurrence after surgery may need the reasons reconsidered. A center with the relevant expertise may provide useful reassessment rather than simply repeat an undirected set of tests. ILAE: Drug-Resistant Epilepsy, definition and clinical resources NICE NG217: Diagnosis and assessment of epilepsy
If the person needs protection after seizures, reminders to take medication, or support with communication and cognition, the companion should understand their usual events and the clinician's emergency plan. The role extends across transfers, accommodation, appointments, and a possible change of return date. The companion should know where rescue medication is kept and how to follow its prescribed instructions.
Before making an inflexible travel commitment, aim to have a clear clinical purpose, receiving department, and appointment scope. The existing clinician should have assessed travel-related concerns, medication and caregiving should be continuous, payment arrangements should be achievable, and responsibility after treatment should be identified. Where important information is missing, an advance consultation or local investigation may be the next useful step.

Quick answer

Deciding whether to seek care in China involves two linked questions: what additional medical value the referral may offer, and whether the person can complete the journey and continuing care safely. Drug resistance does not automatically require international travel. Someone with suitable local services may benefit from an additional opinion without relocating, while a person who has never had a comprehensive assessment should not assume that years of seizures mean there are no further options. The following discussion uses information checked through September 9, 2026 to support planning with the existing clinician and the receiving team in China. Jehi et al.: Timing of referral for epilepsy surgery evaluation, ILAE consensus, 2022 CDC Yellow Book 2026: Travelers with Chronic Illnesses

Full guide

Deciding whether to seek care in China involves two linked questions: what additional medical value the referral may offer, and whether the person can complete the journey and continuing care safely. Drug resistance does not automatically require international travel. Someone with suitable local services may benefit from an additional opinion without relocating, while a person who has never had a comprehensive assessment should not assume that years of seizures mean there are no further options. The following discussion uses information checked through September 9, 2026 to support planning with the existing clinician and the receiving team in China. Jehi et al.: Timing of referral for epilepsy surgery evaluation, ILAE consensus, 2022 CDC Yellow Book 2026: Travelers with Chronic Illnesses

Identify the unresolved medical problem

Some patients continue to have seizures despite several medications but have never been assessed systematically for surgical options. Others have conflicting descriptions of their events, making the treatment rationale uncertain. A person with recurrence after surgery may need the reasons reconsidered. A center with the relevant expertise may provide useful reassessment rather than simply repeat an undirected set of tests. ILAE: Drug-Resistant Epilepsy, definition and clinical resources NICE NG217: Diagnosis and assessment of epilepsy

Ask the current neurologist to summarize the referral question and what has already been tried to answer it. The receiving team can then judge the type of service needed, whether existing records permit an initial discussion, and what requires the patient's attendance. A general wish for a cure without supporting records is not enough to justify a promise of a specific procedure or admission length.

The question can be narrow and practical. For example, it may ask whether a reported lesion and the recorded seizures form a consistent basis for further evaluation. Clarifying that question helps both teams use the visit effectively.

Recognize situations in which specialist reassessment may help

Established drug resistance without comprehensive evaluation, difficult integration of imaging and EEG, a complex syndrome or genetic cause, and a request for a second opinion before invasive treatment are reasonable situations to discuss with the clinician. ILAE guidance on timely surgical evaluation supports considering the available options at an appropriate stage. Jehi et al.: Timing of referral for epilepsy surgery evaluation, ILAE consensus, 2022 Krey et al.: Current practice in diagnostic genetic testing of the epilepsies, ILAE Genetics Commission, 2022

These situations identify a possible need for additional expertise, not an automatic need to obtain it in China. Compare the specific help available locally and at the proposed Chinese center. Language, distance, treatment burden, and the ability to maintain follow-up all belong in that comparison.

The destination should follow the clinical need. Families should not feel they must describe the illness in a particular way to fit an advertised treatment or to justify a journey they have begun considering.

Use advance record review to reduce uncertainty

Original MRI, previous EEG information, event videos, and a treatment timeline may allow a Chinese team to advise whether an in-person visit is likely to be useful. A review can identify missing information, select an appropriate department, and explain what remains to be done after arrival. It generally cannot replace examination, necessary on-site monitoring, or a final presurgical decision. Bernasconi et al.: ILAE structural MRI recommendations and HARNESS protocol, 2019 Tatum et al.: ILAE/IFCN minimum standards for inpatient long-term video-EEG, Epilepsia 2022

An official report of an international multidisciplinary consultation at Fudan Children's Hospital describes substantial advance history gathering and clinician exchanges. This illustrates the work that may be needed. Availability, cost, and submission requirements for such a service must be checked directly; one reported case does not guarantee the same arrangement for every patient. 复旦大学附属儿科医院官方：国际疑难患儿多学科会诊案例，服务组织示例

Keep the distinction between an administrative acceptance of records and a clinical acceptance for a particular treatment. A message confirming receipt of documents should not be interpreted as approval for surgery or research participation.

Obtain local emergency care when the condition is unstable

Prolonged convulsive activity, repeated seizures without recovery, abnormal breathing, serious injury, or a major change in awareness requires urgent medical attention. A patient should not defer an emergency until landing abroad in order to preserve an appointment. After stabilization, clinicians can decide whether transfer is needed and what form of transport is appropriate. CDC: First Aid for Seizures NICE NG217: Treating status epilepticus, repeated or cluster seizures, and prolonged seizures

A marked recent increase in seizures, a new event type, infection, or suspected serious medication reaction also needs assessment before departure. A purchased ticket is not evidence of medical fitness to travel. If postponement is necessary, explain the clinical change to the receiving hospital so arrangements can be reconsidered.

An ordinary passenger journey and a medically supported transfer serve different situations. The treating team should help determine which is appropriate rather than leaving the family to solve an acute medical problem through travel bookings.

Assess fitness for the actual flight

Aviation guidance advises people with neurological conditions to discuss travel with their specialist. Uncontrolled epilepsy or new seizures may require airline medical clearance, and travel after cranial surgery requires confirmation from the neurosurgeon that it is safe. Airlines can impose their own requirements. UK Civil Aviation Authority guidance helps explain these considerations but is not a universal clearance rule for flights in China. UK Civil Aviation Authority: Neurology guidance for airline passengers, current retrieval September 2026

Contact the operating carrier about assistance and medical documentation. Air China's official information states that its special-service applications relate to flights it operates and that changing a ticket may require a fresh application. Codeshare and connecting journeys therefore require checking who actually operates each segment. 中国国际航空：特殊旅客服务方案，实际承运航班需具体核实

The clinical assessment should reflect the current condition and the proposed journey. A general statement obtained months earlier may not address a recent deterioration or operation. Confirm which documents the carrier needs rather than assuming that any medical letter will be sufficient.

Resolve medication continuity before leaving

Ask the prescriber to help plan medication timing across time zones, delays, and the use of any prescribed rescue treatment. Essential medication should remain accessible during the journey and be prepared in accordance with prescription and transport requirements. Do not interrupt treatment for the convenience of border procedures or rely on an unknown substitute to fill a gap. CDC Yellow Book 2026: Travelers with Chronic Illnesses

Some maintenance or rescue medicines contain controlled substances. Requirements may differ at departure, transit, and destination. INCB provides a route to country information, but the relevant authorities or consulate should confirm requirements for the particular medicine, quantity, and documents. Another traveler's uneventful experience is not authorization for the patient's own supply. INCB: National regulations for travelers carrying controlled medicines

Give the receiving hospital a complete medication list in advance. This allows discussion of the treatment being used and any continuity issue that might arise during a longer stay. It does not itself establish permission to import or dispense the medicine.

A companion must be able to provide the care actually needed

If the person needs protection after seizures, reminders to take medication, or support with communication and cognition, the companion should understand their usual events and the clinician's emergency plan. The role extends across transfers, accommodation, appointments, and a possible change of return date. The companion should know where rescue medication is kept and how to follow its prescribed instructions.

Airport assistance may address mobility or navigation, but should not be assumed to provide continuous feeding, toileting, or medical care. Air China's service description identifies limits to several forms of assistance; other carriers need to be checked individually. Needs exceeding the available service must be arranged before departure. 中国国际航空：特殊旅客服务方案，实际承运航班需具体核实

Be realistic about one caregiver's capacity during a long journey. The plan should account for the patient's needs when the companion is tired, handling luggage, or speaking with staff. A clear division of responsibilities can matter as much as the route chosen.

Children need a plan for feeding, development, and travel tolerance

Drug-resistant epilepsy in children may coexist with feeding difficulties, developmental impairment, or difficulty tolerating unfamiliar environments. Share these issues with the pediatric team. A child receiving ketogenic dietary therapy needs a workable food, nutrition, and medication plan during travel. Improvised fasting or a general weight-loss diet is not an equivalent arrangement. Schoeler et al.: International dietetic best practice for ketogenic dietary therapies in children and young people, 2025

Confirm that the receiving service accepts the child's age and syndrome, whether proposed investigations may require sedation, and whether a familiar caregiver can accompany the child. If the child cannot explain discomfort, tell staff how caregivers normally recognize pain, excessive sleepiness, or an unusual event.

The itinerary should fit the child's abilities. A plan based only on the adult travel schedule may underestimate the time and support needed for feeding, communication, and recovery from a disrupted routine.

Include the return journey when considering surgery

A patient traveling for evaluation may ultimately be advised against surgery. Someone who is suitable may need further investigations or a procedure different from the initial possibility. Discuss these branches before leaving and allow room for decision-making and recovery. The hospital discharge date is not automatically an appropriate flight date. UCLH: A guide for patients considering epilepsy surgery Oxford University Hospitals: After epilepsy surgery

After cranial surgery, review of imaging, the wound, or neurological function may be needed before travel. The treating team and carrier should confirm the relevant fitness and transport requirements. If the return journey must change, the patient still needs access to medication, accommodation, and care.

An inflexible itinerary can make a clinically reasonable option difficult to carry out. Ask what would happen if further assessment or recovery takes longer than expected, without asking clinicians to guarantee a date that the evidence cannot support.

Establish care at home before implantation or a major drug change

For neurostimulation, find out whether a clinician near home can manage the proposed device and how programming and technical records will be transferred. Continuing assessment is part of the treatment. The ability to implant a system in China does not by itself resolve the support needed afterward. NINDS: Deep Brain Stimulation

A new medicine also requires a lawful prescribing route, ongoing access, and appropriate monitoring after return. Approval in China, approval in the home country, hospital availability, and suitability for the individual are separate issues. The plan should permit safe continuation rather than leave the family searching for a prescriber when the initial supply runs out. NICE NG217: Principles of treatment, safety, monitoring and withdrawal 翼思生物官方产品资料：西诺氨酯2025年在中国获批成人部分性发作适应证

If the home clinician cannot provide a required service, discuss alternatives before treatment starts. The answer may be another follow-up arrangement or a different treatment pathway, depending on the clinical situation.

Confirm a trial pathway before traveling for research

A development announcement does not establish an available enrollment place. Subtype, age, genetic findings, previous treatments, and stable medication requirements can all affect eligibility. Even an initially suitable person needs formal screening and consent. Travel expenses should not be committed before the family has clarified the proposed research pathway with the center. NIH: Clinical research and trials, the basics for participants 中国药物临床试验质量管理规范，2026修订全文

Ask about visit frequency, randomization, treatment after the study or after withdrawal, and which costs the study covers. A trial requiring repeated international journeys or a prolonged local stay may create a substantial practical burden even if the study drug is supplied.

An investigational treatment is not a product that can be obtained by bypassing research procedures. Keep the study identifier and formal center contact details, and separate exploratory interest from actual acceptance into the study.

Financial and language arrangements affect whether the plan is workable

Consider additional investigations, a longer stay, and follow-up at home as well as the first consultation. Commercial insurance coverage for established epilepsy, planned overseas treatment, or a specific procedure requires the insurer's confirmation. A hospital's direct-billing relationship does not automatically mean every expense is covered. 北京协和医院国际医疗部：商业保险常见问题及直付边界

Language support must extend to important records, clinical explanations, and consent. A person who can arrange accommodation may not be able to interpret a complex discussion of seizure localization or surgical risk accurately. Ask how the hospital provides communication support and allow the patient time to understand and question the proposed plan.

The patient's preferences should remain visible during these discussions. Under pressure, a family may hear that something is technically possible without fully understanding the conditions or limits. Written clarification can help everyone return to the same information.

Turn the decision into a set of confirmed arrangements

Before making an inflexible travel commitment, aim to have a clear clinical purpose, receiving department, and appointment scope. The existing clinician should have assessed travel-related concerns, medication and caregiving should be continuous, payment arrangements should be achievable, and responsibility after treatment should be identified. Where important information is missing, an advance consultation or local investigation may be the next useful step.

For a family still uncertain, ask both teams what should happen soon if the patient does not travel and what additional judgment the visit to China is expected to provide. The answer need not be immediate departure. Postponement, staged assessment, or continued local care can all be reasonable when they address the real clinical problem and support safety.

Destination health advice for China can help complete general travel preparation, but it does not replace individualized epilepsy assessment. The decision is strongest when the medical purpose and the practical ability to carry out the plan are both clear. CDC Travelers Health: China destination advice, current retrieval September 2026